Navigation Links
BioNano Genomics Announces The Purchase Of The Irys System By The Chinese Academy Of Sciences And Tel Aviv University

SAN DIEGO, BEIJING, and TEL AVIV, Israel, Oct. 25, 2013 /PRNewswire/ -- BioNano Genomics announced today the purchase of two IrysTM Systems to be placed at the Chinese Academy of Sciences in Beijing and the School of Chemistry at the Tel Aviv University in Tel Aviv, Israel. These new placements are designed to run the recently released high-throughput chip, IrysChipTM V2, which supports human genome analysis.

"Our new high-throughput chip shows the Irys System can scale to large complex genomes, which is critical to its utility throughout human genomics and epigenomics," said Han Cao, Ph.D., founder and chief scientific officer of BioNano Genomics.  "The Irys System is a versatile and sensitive single molecule imaging platform that allows researchers to rapidly identify structural information over long-range distances with minimal alteration of the native genomic samples. This ability enables them to assemble de novo genomes containing complex, highly variable regions, as well as map epigenomics patterns using various labeling schemes, which are currently in advanced development."

This purchase marks the first academic order of the Irys System in Asia, and Bin Liu, Ph.D., will be the principal investigator leading the adoption of Irys for the Chinese Academy of Sciences. He heads the Center of Systematic Genomics at Xinjiang Institute of Ecology and Geography and Institute of Oceanology. Dr. Liu's team will use the Irys System for a wide variety of applications to study eco-systems and bioresources in marine sciences and in arid desert lands, where highly complex genomes are found.

Dr. Liu stated, "We have followed the development of the next-generation of physical mapping technologies closely. Integration of short-read, next-generation sequencing with long-range physical maps has long been the standard of genomics. Today, Irys has started the last step of genome characterization in a way that researchers and practitioners originally envisioned. Most of these are in a category of de novo non-model species. We will not settle for anything less than the complete picture."

At Tel Aviv University, Dr. Yuval Ebenstein leads the NanoBioPhotonics Lab and will oversee the adoption of Irys. His team is advancing technologies to directly visualize the individual epigenetic modifications in an individual genome. Epigenetics is the study of how gene expression is regulated, via proteins, methylation and other modifications, without altering the underlying DNA sequence. By creating genome maps from individual DNA molecules, up to 1 million base pairs in length, they are unlocking important genetic and epigenetic information about how genes are activated or silenced.  Knowing how and why genes are turned on and off is significant to understanding many aspects underlying basic biology, including development, evolution and human disease.

"Next generation sequencing is advancing the genomic exploration in all fields of biology, but it fails to extract the full range of information associated with genetic material," said Yuval Ebenstein, Ph.D., Senior Lecturer, School of Chemistry, Tel Aviv University. "By directly visualizing DNA, we are able to get important insights into genome structural variation and epigenetic marks that are not accessible through sequencing or DNA arrays."

The Chinese Academy of Sciences and the Tel Aviv University are among the latest to adopt the Irys System. Others include the New York Genome Center, who are using their Irys for human and cancer genomics, UC San Francisco, for genomic investigations of a range of species from viruses to humans, and Kansas State University, for the i5k Insect and other Arthropod Genome Sequencing Initiative.

About Irys

Irys makes it possible to routinely and accurately detect genomic structural variation and to finish genome assemblies. The fully automated Irys benchtop instrument uses the IrysChip to uncoil and confine long DNA molecules in proprietary Nanochannel Arrays™ where they are uniformly linearized in a highly parallel display for high-resolution, single-molecule imaging. Irys does not employ DNA fragmentation or amplification, which are typical with next-generation sequencing. The result is sequence information over extremely long "reads" ranging from hundreds of kilobases to a megabase, where the sample's valuable structural information is preserved. Irys makes it possible for researchers to directly observe structural variants including replications, deletions, translocations and inversions.

About BioNano Genomics

Headquartered in San Diego, BioNano Genomics is delivering an altogether better way of gaining a fully informed understanding of genomes. The Company's platform provides researchers and clinicians the most comprehensive, organized and actionable picture of a genome with unprecedented insights into how the individual components of genomes are ordered, arranged, and interact with each other. BioNano Genomics works with institutions in life science, translational research, molecular diagnostics and personalized medicine. The Company is supported by private investors and grant funding from genomics programs at federal agencies, including the NIH and NIST-ATP.

Notes: BioNano Genomics is a trademark of BioNano Genomics, Inc. Any other names of actual companies, organizations, entities, products or services may be the trademarks of their respective owners.

SOURCE BioNano Genomics
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. BIT Group Partners with BioNano Genomics to Produce Revolutionary Genomics Platform
2. BioNano Genomics lanza Irys en Europa en ESHG 2013
3. BioNano Genomics f├╝hrt auf ESHG 2013 Irys in Europa ein
4. BioNano Genomics Launches Irys In Europe At ESHG 2013
5. NextCODE Health Launches Operations with Exclusive License to Leverage deCODE genetics Genomics Platform for Sequence-Based Clinical Diagnostics, and $15 Million in Venture Financing
6. Claritas Genomics to Sequence Exomes for VA Million Veteran Program with Ion Torrent Next-Generation Sequencers
7. Chinese Leader in Genomics Joins Science Center's Port Community
8. Real Time Genomics Launches Two New Products in Human Disease Research
9. Clinical Genomics & Informatics Europe Announce New Keynotes & Final Program
10. Complete Genomics and Illumina Settle Patent Litigation
11. Rosetta Genomics Executes Credentialing Agreement with Three Rivers Provider Network
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... Organization of Black Aerospace Professionals (OPBAP) has been formalized with the signing of ... team leaders met with OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn ...
(Date:11/24/2015)... Malaysia , Nov. 24, 2015  Asia-Pacific ... contract research organisation (CRO) market. The trend of ... in lower margins but higher volume share for ... capacity and scale, however, margins in the CRO ... Organisation (CRO) Market ( ), finds ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... Inc., a worldwide provider of clinical research services headquartered in ... has set a new quarterly earnings record in Q3 of 2015.  ... Q3 of 2014 to Q3 of 2015.   ... the establishment of an Asia-Pacific office to ... and Mexico , with the establishment ...
Breaking Biology Technology:
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
(Date:10/29/2015)... , Oct. 29, 2015  The J. Craig ... report titled, "DNA Synthesis and Biosecurity: Lessons Learned and ... Department of Health and Human Services guidance for synthetic ... 2010. --> --> ... also has the potential to pose unique biosecurity threats. ...
Breaking Biology News(10 mins):